Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CHRS
#3090
Coherus Oncology, Inc. Common Stock
1.740
0
USD
+2.96%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+2.96%
Mudança mensal
+9.43%
Mudança em 6 meses
+8.07%
Mudança anual
+8.07%
Fechamento anterior
1.690
0
Open
1.740
0
Bid
Ask
Low
1.740
0
High
1.740
0
Volume
40
Mercados
Ações
Cuidados de saúde
CHRS
Open full chart
Financials
Overview
Relatórios
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
115.9 M
115.93 M
116.23 M
120.87 M
149.89 M
—
Valuation ratios
Enterprise value
33.95 M
11.15 M
-131.9 M
94.88 M
123.96 M
98.09 M
Price to earnings ratio
5.52
-0.7
0.48
1.25
0.99
2.02
Price to sales ratio
0.59
0.24
0.25
0.68
3.94
5.11
Price to cash flow ratio
7.75
-108.9
1.06
2.12
1.2
-104.51
Price to book ratio
1.2
0.19
0.16
0.36
2.73
3.44
Enterprise value to EBITDA ratio
0.28
0.38
2.28
-0.99
57.18
58.84
Profitability ratios
Return on assets %
-0.22
0.15
0.68
0.07
-0.86
0.04
Return on equity %
-0.74
0.31
2.48
0.4
-3.64
-0.44
Return on invested capital %
—
—
—
—
-45.38
—
Gross margin %
55.06
65.09
66.89
67.84
68.27
268.09
Operating margin %
-17.16
597.91
443.59
383.14
359.9
1 784.54
EBITDA margin %
16.86
-606.41
-450.58
-388.89
-364.57
-1 810.45
Net margin %
-39.48
744.43
2 903.91
307.07
-1 740.22
2 215.19
Liquidity ratios
Quick ratio
0.96
1.2
1.43
1.23
1.45
5.31
Current ratio
1.21
1.22
1.44
1.24
1.47
5.37
Inventory turnover
1.9
0.07
0.85
1.13
1.55
3.6
Asset turnover
0.52
0.02
0.03
0.02
0.03
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.51
0.62
—
—
—
—
Long term debt to total equity ratio
1.73
1.25
—
—
—
—
Per share metrics
Operating cash flow per share
-0.25
0.22
0.4
0.4
0.17
1.19
EBIT per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.59
EBITDA per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.58
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.71
2.05
1.65
1.47
5.88
Net current asset value per share
2.97
2.68
3.28
3.97
1.76
11.68
Tangible book value per share
0.68
1.13
0.58
0.33
0.13
2.16
Working capital per share
0.51
0.48
1
0.76
0.57
2.81
Book value per share
1.15
1.58
1.03
0.76
0.52
3.89
Notícias
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Coherus BioSciences na Conferência Citizens: mudança estratégica para oncologia
Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift
Oppenheimer reafirma classificação de ações da Coherus Biosciences como Outperform
Oppenheimer reiterates Coherus Biosciences stock rating at Outperform
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
Lucro da Coherus BioSciences veio em linha com as projeções; receita menor do que estimativas
Coherus BioSciences earnings matched, revenue fell short of estimates
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates
Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates